ABSTRACT NUMBER: ESOC2026A1022 THE IMPACT OF CARDIAC THROMBI ON OUTCOME AFTER REPERFUSION THERAPIES IN ACUTE ISCHAEMIC STROKE

Abstract Background and aims Cardiac thrombi detected on CT in acute ischaemic stroke (AIS) can provide important prognostic information. We determined the association between cardiac thrombi and outcomes following reperfusion therapies in AIS. Methods This was a sub-analysis of international multicentre AIS of HEARTS collaboration which included AIS patients receiving reperfusion therapy at the study centres between 2018 and 2024. We evaluated the association between cardiac thrombi and 90-day clinical outcomes. Results Reperfusion therapy was administered to 1804 patients: 863 (47.8%) with IV thrombolysis only, 594 (32.9%) with EVT only, and 347 (19.2%) were treated with both IVT and EVT. Functional independence (mRS 0-2) was achieved in 987 (54.7%) patients. Patients achieving independent outcome were younger (median age 70 vs 79, p<0.001), had a lower baseline NIHSS (6 vs 13, p<0.001), with less known AF (17.6% vs 30.7%, p<0.001), less large vessel occlusion (45.8% vs 60.4%, p<0.001), and less cardiac thrombi on CT (4.1% vs 8.9%, p<0.001). The presence of cardiac thrombi was associated with reduced chance of functional independence (OR 0.624, 95% CI 0.385–1.012; p=0.056) after adjusting for age, sex, pre-morbid mRS, baseline NIHSS and LVO. All-cause 90-day mortality was 15.2%, with a trend towards increased mortality in patients with cardiac thrombi (OR 1.555, 95% CI 0.940-2.572; p=0.086). Conclusions Cardiac thrombus was associated with worse functional outcome and increased mortality among patients receiving reperfusion therapies for AIS. Conflict of interest Shuyu Guo: nothing to disclose. Shan Sui Nio: nothing to disclose. Md Golam Hasnain: nothing to disclose. Daniel S. Green: Nil conflicts of interest. This research was supported by the Australian Government Research Training Program Scholarship. Alexander Berry-Noronha: nothing to disclose. John Fink: nothing to disclose. Mark Parsons: nothing to disclose. Carlos Garcia-Esperon: nothing to disclose. Teddy Wu: nothing to disclose. Jonathan Coutinho: nothing to disclose.

Authors

Institutions

Publication Details

Journal
European Stroke Journal
Published
2026-05-01
DOI
https://doi.org/10.1093/esj/aakag023.517
Primary Topic
Acute Ischemic Stroke Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ABSTRACT NUMBER: ESOC2026A1022 THE IMPACT OF CARDIAC THROMBI ON OUTCOME AFTER REPERFUSION THERAPIES IN ACUTE ISCHAEMIC STROKE

Teddy Wu, Shan Sui Nio, Jonathan Coutinho, Shuyu Guo et al.
European Stroke Journal
Acute Ischemic Stroke Management
article

ABSTRACT NUMBER: ESOC2026A1022 THE IMPACT OF CARDIAC THROMBI ON OUTCOME AFTER REPERFUSION THERAPIES IN ACUTE ISCHAEMIC STROKE

Teddy Wu, Shan Sui Nio, Jonathan Coutinho, Shuyu Guo, Daniel Green, John Fink, Alexander Berry-Noronha, Mark Parsons, Carlos Garcia-Esperon, M D Golam Hasnain
article en

Abstract

Abstract Background and aims Cardiac thrombi detected on CT in acute ischaemic stroke (AIS) can provide important prognostic information. We determined the association between cardiac thrombi and outcomes following reperfusion therapies in AIS. Methods This was a sub-analysis of international multicentre AIS of HEARTS collaboration which included AIS patients receiving reperfusion therapy at the study centres between 2018 and 2024. We evaluated the association between cardiac thrombi and 90-day clinical outcomes. Results Reperfusion therapy was administered to 1804 patients: 863 (47.8%) with IV thrombolysis only, 594 (32.9%) with EVT only, and 347 (19.2%) were treated with both IVT and EVT. Functional independence (mRS 0-2) was achieved in 987 (54.7%) patients. Patients achieving independent outcome were younger (median age 70 vs 79, p<0.001), had a lower baseline NIHSS (6 vs 13, p<0.001), with less known AF (17.6% vs 30.7%, p<0.001), less large vessel occlusion (45.8% vs 60.4%, p<0.001), and less cardiac thrombi on CT (4.1% vs 8.9%, p<0.001). The presence of cardiac thrombi was associated with reduced chance of functional independence (OR 0.624, 95% CI 0.385–1.012; p=0.056) after adjusting for age, sex, pre-morbid mRS, baseline NIHSS and LVO. All-cause 90-day mortality was 15.2%, with a trend towards increased mortality in patients with cardiac thrombi (OR 1.555, 95% CI 0.940-2.572; p=0.086). Conclusions Cardiac thrombus was associated with worse functional outcome and increased mortality among patients receiving reperfusion therapies for AIS. Conflict of interest Shuyu Guo: nothing to disclose. Shan Sui Nio: nothing to disclose. Md Golam Hasnain: nothing to disclose. Daniel S. Green: Nil conflicts of interest. This research was supported by the Australian Government Research Training Program Scholarship. Alexander Berry-Noronha: nothing to disclose. John Fink: nothing to disclose. Mark Parsons: nothing to disclose. Carlos Garcia-Esperon: nothing to disclose. Teddy Wu: nothing to disclose. Jonathan Coutinho: nothing to disclose.

European Stroke JournalVol. 11(Supplement_1)
John Hunter Hospital (AU), Liverpool Hospital (AU), Christchurch Hospital (NZ), Amsterdam Neuroscience (NL), Ingham Institute (AU), South Western Sydney Local Health District (AU), Western Sydney University (AU), University of Otago (NZ), University of Amsterdam (NL)
Openalex Percentile: Top 9%
Acute Ischemic Stroke Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.